GTCR and Gregory T. Lucier Announce Merger of Surgical ... | 合法醫療器材資訊網

2021年2月8日—Lucier,CorzaHealth,hassimultaneouslyacquiredandmergedSurgicalSpecialtiesCorporation(“SurgicalSpecialties”)andtheTachoSil®Fibrin ...

CHICAGO and WESTWOOD, Mass., Feb. 1, 2021 /PRNewswire/ — GTCR, a leading private equity firm, announced today that its management partnership with Gregory T. Lucier, Corza Health, has simultaneously acquired and merged Surgical Specialties Corporation (“Surgical Specialties”) and the TachoSil® Fibrin Sealant Patch (“TachoSil”) to create a new company, Corza Medical[1]. Surgical Specialties is a medical technology company focused on high-performance surgical sutures and ophthalmic knives. TachoSil, previously owned by Takeda Pharmaceutical Company Limited, is a differentiated surgical patch product line used to enable safe and fast bleeding control during surgeries.

The company will be led by Executive Chairman Gregory T. Lucier and Chief Executive Officer Dan Croteau, with a global team of over 1,700 employees supporting clinicians, distributors and ...